Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 7/20 | 0.73 |
| ▸ | CTSK | P43235 | 6/20 | 0.50 |
| ▸ | CTSL | P07711 | 3/20 | 0.48 |
| ▸ | HTRA1 | Q92743 | 1/20 | 0.47 |
| ▸ | CTSS | P25774 | 1/20 | 0.47 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20880287 | 0.97 | CAPN1 (0.75) | CAPN1CTSKCTSLHTRA1CTSS | |
| SCHEMBL13954301 | 0.97 | CAPN1 (0.75) | CAPN1CTSKCTSLHTRA1CTSS | |
| SCHEMBL13954130 | 0.97 | CAPN1 (0.75) | CAPN1CTSKCTSLHTRA1CTSS | |
| SCHEMBL20834985 | 0.89 | CAPN1 (0.75) | CAPN1CTSKCTSLCTSS | |
| SCHEMBL21458032 | 0.89 | CAPN1 (0.75) | CAPN1CTSKCTSLCTSS | |
| SCHEMBL4402033 | 0.89 | CAPN1 (0.75) | CAPN1CTSKCTSLCTSS | |
| SCHEMBL20474484 | 0.88 | CAPN1 (0.76) | CAPN1CTSKCTSLHTRA1CTSS | |
| SCHEMBL20474487 | 0.88 | CAPN1 (0.76) | CAPN1CTSKCTSLHTRA1CTSS | |
| SCHEMBL4395935 | 0.87 | CAPN1 (0.72) | CAPN1CTSKCTSLCTSS | |
| SCHEMBL21458034 | 0.87 | CAPN1 (0.72) | CAPN1CTSKCTSLCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7491705-B2 | Alpha-ketoamide derivative, and production method and use thereof | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2009-02-17 | — | — | US | disclosed |
| US-20070004643-A1 | Alpha-ketoamide derivative, and production method and use thereof | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2007-01-04 | — | — | US | disclosed |
| WO-2005056519-A1 | ALPHA-KETOAMIDE DERIVATIVE, AND PRODUCTION METHOD AND USE THEREOF | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2005-06-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070004643-A1 | Alpha-ketoamide derivative, and production method and use thereof | CAPN1, CAPN2, CAPNS1 | CAPN1 1/4885CTSK 251/4885CTSL 311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.